Promising Pathway Act 2.0

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [S. 4426 Introduced in Senate (IS)] <DOC> 118th CONGRESS 2d Session S. 4426 To amend the Federal Food, Drug, and Cosmetic Act to establish a time- limited conditional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES May 23, 2024 Mr. Braun (for himself, Mrs. Gillibrand, Mr. Cramer, Mr. Manchin, Mr. Schmitt, Mr. Padilla, Mr. Vance, Mr. Booker, Mr. Hawley, Mr. Welch, and Ms. Murkowski) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to establish a time- limited conditional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. Th…